Skip to content
Open access

Transcription factor-driven metabolic stratification reveals glycolytic and lipogenic subtypes with distinct prognostic and functional features in pancreatic cancer

Oct 2026 · Frontiers in Oncology · Vol 16 · 0 citations · 48 references
Medicine

TL;DR

TF-based classification delineates glycolytic and lipogenic subtypes in PDAC, underscoring the critical role of TF-regulated metabolic programs in patient stratification and support the development of metabolism-targeted therapeutic strategies.

Abstract

Objective Pancreatic ductal adenocarcinoma (PDAC) exhibits profound molecular and metabolic heterogeneity associated with distinct phenotypic states. However, the contribution of transcription factor (TF)-driven regulatory programs to metabolic subtype stratification remains poorly understood. This study aims to determine whether TF-based classification can identify prognostically relevant glycolytic and lipogenic PDAC subtypes. Methods Bulk transcriptomic data from multiple PDAC cohorts and single-cell RNA sequencing data were integrated to characterize TF-associated metabolic heterogeneity. Metabolic signatures and TFs were quantified using single-sample gene set enrichment analysis (ssGSEA) and AddModule Score (AMS). Differential expression, enrichment analysis, integrative bulk and single-cell transcriptomic analysis, and deep neural network-based metabolic flux modeling were performed to investigate metabolic programs and functional differences between TF-defined subtypes. Additionally, RNA interference, RT-qPCR, lipid droplets staining, lactate assay, and transwell assays were used to evaluate the roles of TP63 in metabolic regulation. Results Glycolytic and lipogenic TF-defined metabolic subtypes were identified across multiple independent PDAC cohorts. These subtypes exhibited distinct metabolic programs, differentiation states, and prognostic outcomes. The glycolytic TF-defined subtype was associated with worse prognosis and differentiation, whereas the lipogenic TF-defined subtype exhibited more favorable clinical features. Integration of public bulk and single-cell transcriptomic analyses, together with deep neural network-based metabolic flux modeling, revealed consistent metabolic heterogeneity at both cellular and functional levels. Notably, TP63 was identified as a potential regulator of glycolytic-lipogenic metabolic reprogramming in PDAC. Conclusions TF-based classification delineates glycolytic and lipogenic subtypes in PDAC, underscoring the critical role of TF-regulated metabolic programs in patient stratification. These findings highlight the prognostic significance of glycolytic and lipogenic metabolic heterogeneity and support the development of metabolism-targeted therapeutic strategies.

Read PDF

Similar papers

Sep 2026

Glutamine Metabolism-associated Molecular Heterogeneity and Prognosis in Pancreatic Adenocarcinoma.

BACKGROUND Pancreatic Adenocarcinoma (PAAD) is characterized by pronounced molecular heterogeneity and profound metabolic reprogramming. Glutamine metabolism plays a critical role in sustaining tumor growth and shaping the tumor microenvironment; however, its contribution to molecular heterogeneity, immune characterist...

Wen-Yu Li, Min Luo, Xue-Hong Wang et al. · 0 citations
Open access Oct 2026

Single-cell analysis identifies an LDL metabolism–associated myeloid signature and tumor cell–intrinsic ITGA5 in HNSCC

Lipid metabolic reprogramming is a hallmark of tumor progression, yet the role of low-density lipoprotein (LDL) metabolism in head and neck squamous cell carcinoma (HNSCC) remains unclear. This study aimed to systematically characterize LDL metabolism and identify clinically relevant regulators. Integrated...

Heng Ma, Shiwei Wang, Lu-Dan Xiong et al. · 0 citations
Open access Sep 2026

Macrophage-linked lipid metabolic signatures for HCC prognosis identified through integrated bulk and single-cell transcriptomics

Background Macrophage-dependent immune remodeling and altered lipid metabolism are closely related to liver cancer behavior. In hepatocellular carcinoma (HCC), the survival relevance of macrophage-associated lipid metabolism genes (MLMGs) remains insufficiently characterized. This work evaluated MLMG-related molecular...

Yu Yang, Man-Man Lu, Huapeng Zhang et al. · 0 citations
Open access Sep 2026

Integrative Transcriptomic Analysis and Functional Validation Implicate GPT2 in Glycolytic Regulation in Polycystic Ovary Syndrome

These findings provide a comprehensive characterization of glycolytic dysregulation in PCOS and identify GPT2 as a potential metabolic regulator linking altered energy metabolism to ovarian dysfunction, and provide a molecular framework for future studies investigating metabolism‐ and nutrition‐based intervention strat...

Mei-Li Xi, Rong-Kui Luo, Jia-Rong Zhang et al. · 0 citations
Open access Oct 2026

Integrated single-cell and experimental analyses identify HMGA1 as a candidate regulator of lactate-responsive metabolic–immune crosstalk in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is characterized by extensive metabolic reprogramming, and immune evasion is closely linked to dysregulated lactate metabolism. However, the tumor-intrinsic mechanisms that translate extracellular lactate signals into Treg-associated immune remodeling remain poorly understood. Here,...

Wei Lai, Ke-Wei Wang, Hao-Jie Yu · 0 citations
Oct 2026

From Single-Cell Sequencing Data Analysis to Functional Validation: XCL1 is Associated with Glycolytic Metabolism in Oral Squamous Cell Carcinoma.

XCL1 is associated with glycolysis-related metabolic alterations and OSCC cell growth in vitro, which support further investigation of XCL1 in OSCC, while in vivo studies and larger clinical cohorts are needed to further evaluate its biological and therapeutic relevance.

Li-Ru Zhang, Wei Liu, Di Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.